Background/Objectives: Subcutaneous adipose tissue grows rapidly during the first months of life. Lipoprotein lipase (LPL) has a quantitatively important function in adipose tissue fat accumulation and insulin-like growth factor-I (IGF-I) is a determinant of neonatal growth. Recent studies showed that LPL mass in non-heparinized serum (LPLm) was an index of LPL-mediated lipolysis of plasma triacylglycerol (TG). The objective was to know the influence of serum LPL and IGF-I on neonatal subcutaneous fat growth, especially on catch-up growth in low birth weight infants. Subjects/Methods: We included 47 healthy neonates (30 males, 17 females), including 7 small for gestational age. We measured serum LPLm and IGF-I concentrations at birth and 1 month, and analyzed those associations with subcutaneous fat accumulation. Results: Serum LPLm and IGF-I concentrations increased markedly during the first month, and positively correlated with the sum of skinfold thicknesses both at birth (r ¼ 0.573, P ¼ 0.0001; r ¼ 0.457, P ¼ 0.0035) and at 1 month (r ¼ 0.614, Po0.0001; r ¼ 0.787, Po0.0001, respectively). In addition, serum LPLm concentrations correlated inversely to very low-density lipoprotein (VLDL)-TG levels (r ¼ À0.692, Po0.0001 at birth; r ¼ À0.429, P ¼ 0.0052 at 1 month). Moreover, the birth weight Z-score had an inverse association with the postnatal changes in individual serum LPLm concentrations (r ¼ À0.639, Po0.0001). Conclusions: Both serum LPLm and IGF-I concentrations were the determinants of subcutaneous fat accumulation during the fetal and neonatal periods. During this time, LPL-mediated lipolysis of VLDL-TG may be one of the major mechanisms of rapid growth in subcutaneous fat tissue. Moreover, LPL, as well as IGF-I, may contribute to catch-up growth in smaller neonates.
Introduction
Recently, many studies have shown that infants that were small for gestational age had a high risk for developing obesity and metabolic syndrome in the future (Barker et al., 1993) . In addition, the risks were higher in infants with early catch-up growth (Ong et al., 2000) . Therefore, weight gain during early infancy is a potential target for preventive intervention.
However, the precise mechanism of this rapid catch-up growth in small for gestational age infants is unclear. In normal weight infants, subcutaneous adipose tissue grows rapidly during the first months of life in parallel with the change in fat cell size; however, the number of fat cells remains stable (Häger et al., 1977; Knittle et al., 1979; Soriguer Escofet et al., 1996) . This process is regulated by several endocrine and nutritional factors (Symonds et al., 2003) , including insulin-like growth factor-I (IGF-I) (Skalkidou et al., 2003) .
Lipoprotein lipase (LPL) is one of the important factors for lipid deposition in adipose tissue (Zechner et al., 2000) . An in vitro study with 3T3-L1 pre-adipocytes showed that during differentiation, LPL mRNA expression increased sixfold; this resulted in a twofold increase in cell surface-associated LPL and a 10-fold increase in intracellular lipid storage (Gonzales and Orlando, 2007) . In in vivo study with chickens, the administration of monoclonal antibodies against LPL in adipose tissue caused inhibition of LPL-mediated hydrolysis of very low-density lipoprotein (VLDL), and consequently, the adipose fat weight was reduced (Sato et al., 1999) . In addition, studies using genetically engineered mouse models showed that LPL activity is a major determinant of adipose tissue development (Voshol et al., 2009) . Taken together, these studies showed that LPL has a quantitatively important function in adipose tissue fat accumulation.
Mature LPL is bound to the vascular endothelium and is released by heparin; therefore, its activity is commonly assayed in blood samples after the injection of heparin. Over the last decade, several studies showed that LPL mass in non-heparinized serum (LPLm) was a useful, physiologically relevant index of LPL-mediated lipolysis of plasma triacylglycerol (TG), because of low concentrations in LPL-deficient patients (Kern et al., 1990; Kobayashi et al., 1993) and significant relationships between serum LPLm, lipids, lipoproteins, and insulin resistance (Kobayashi et al., 1993 (Kobayashi et al., , 2007 Tornvall et al., 1995; Watanabe et al., 1999; Hanyu et al., 2007; Saiki et al., 2007) . The aim of this study is to know the influence of LPL on neonatal subcutaneous fat growth. We measured serum LPLm concentrations in neonates at birth and 1 month of age, and analyzed associations with the serum lipoprotein profile. Furthermore, we investigated the impact of serum LPLm concentrations on subcutaneous fat accumulation, as well as serum IGF-I concentrations, especially on catch-up growth in low birth weight infants.
Materials and methods

Subjects
Informed consent was obtained from all parents, and the study was approved by the University Ethics Committee (Nihon University, Itabashi Hospital).
From October 2007 to September 2008, we included 47 consecutive, healthy neonates (30 males, 17 females), including 7 small for gestational age infants (birth weight oÀ2.0 s.d.). The inclusion criteria were neonates that were born by uneventful vaginal delivery or cesarean operation in the maternity ward of our university hospital. The exclusion criteria were infants whose mothers had experienced complications and infants that had asphyxia at birth, intrauterine infections, or organic disorders. Anthropometric parameters, serum LPLm, IGF-I, and lipoprotein concentrations were analyzed at birth and at 1 month of age. Feeding information (that is exclusively breast fed, exclusively formula fed, mixed breast and formula fed) was obtained from each mother 1 month after each child's birth.
Anthropometry
The body weight of each neonate was determined to the nearest gram with an electronic scale. The body length was measured to the nearest 0.1 cm in the supine position with a length board. Triceps, biceps, suprailiac, and subscapular skinfold thicknesses were measured on the left side of the body with a skinfold caliper (Holtain Ltd, Crosswell, Crymych, UK), according to the procedure reported by Schmelzle and Fusch (2002) . Subcutaneous fat accumulation was evaluated as the sum of these four skinfold thicknesses.
Serum assays
At birth, cord blood sampling was performed from the umbilical vein after double clamping of the umbilical cord. At 1 month of age, venous blood was obtained by venipuncture just before infants were fed. Serum LPLm concentrations were measured by a sandwich enzyme-linked immunosorbent assay using a specific monoclonal antibody against LPL (Daiichi Pure Chemicals, Tokyo, Japan), as reported by Kobayashi et al. (1993) . Serum IGF-I concentrations were analyzed by immunoradiometric assay kit (FUJI-FILM RI Pharma Co., Ltd, Tokyo, Japan). Serum lipoprotein analyses were performed by high-performance liquid chromatography with gel permeation columns (LipoSEARCH; Skylight-Biotec, Inc., Akita, Japan) (Okazaki et al., 2005) .
Statistical analyses
All statistical analyses were conducted using the statistical package, STATVIEW, version 4.5 (Abacus Concepts, Berkeley, CA, USA). Data are given as the mean±standard deviation. The significance of differences in measured parameters between sexes and between at birth and at 1 month was analyzed by Mann-Whitney U-test and a parametric method (paired t-test), respectively. The differences among three feeding groups were analyzed by ANOVA test. Simple and multiple regressions were used to assess the correlation between variables. A P-value o0.05 was considered to indicate statistical significance.
Results
The characteristics of the study subjects are shown in Table 1 . Body weight and body length at birth were significantly greater in males; however, the differences disappeared at 1 month. The gains in body weight and height during the first month were 1160.3 ± 659.6 g and 5.3 ± 2.6 cm in males, 1081.4 ± 634.0 g and 6.1 ± 2.7 cm in females, without significant sex differences. With respect to lipoprotein profiles, no difference was shown between the sexes. Lowdensity lipoprotein cholesterol, high-density lipoprotein cholesterol, and VLDL-TG concentrations increased significantly during the first month of life (Po0.0001, Po0.0001, Po0.0001, respectively). Serum IGF-I concentrations also increased (240.5±231.2%) without sex difference. Serum LPLm concentrations in males and females were 57.5±22.1 and 51.9 ± 23.2 ng/ml at birth and 100.8 ± 29.7 and 91.1 ± 30.0 ng/ml at 1 month, respectively. Thus, males had higher serum LPLm concentrations, but the differences did not reach statistical significance. The serum LPLm concentration increased in all but two subjects during the first month of life by an increment of 41.0 (À12.0-122.0) ng/ml or 111.6 (À14.8-577.8)%.
In simple regression analyses (Table 2) , at birth, the serum LPLm concentration in cord blood was significantly associated with birth weight and the sum of skinfold thicknesses, but not with gestational age or body length. At 1 month of age, the serum LPLm concentration correlated positively to body weight, body length, and the sum of skinfold thicknesses. In addition, the serum LPLm concentration had an inverse relationship with the VLDL-TG concentration and a positive relationship with the high-density lipoprotein cholesterol concentration both at birth and at 1 month of Serum lipoprotein lipase mass concentration and subcutaneous fat accumulation K Yoshikawa et al age. The serum IGF-I concentration also correlated positively with body weight (r ¼ 0.443, P ¼ 0.0018, r ¼ 0.751, Po0.0001) and the sum of skinfold thicknesses (r ¼ 0.547, P ¼ 0.0035, r ¼ 0.787, Po0.0001) both at birth and 1 month, respectively. In multiple regression analyses (Table 3) , however, the serum LPLm concentration was the only significant determinant explaining the sum of skinfold thicknesses at birth. On the other hand, at 1 month, both the serum IGF-I and LPLm concentrations emerged as significant and independent determinants explaining 65.4% of the variability. The changes in the individual sums of skinfold thicknesses during the first month was 8.3±6.9 mm. This change correlated positively with the serum LPLm concentration (r ¼ 0.638, Po0.0001) and IGF-I (r ¼ 0.730, Po0.0001) at 1 month, but not with the LPLm concentration (r ¼ 0.026, P ¼ 0.8730) or IGF-I (r ¼ 0.200, P ¼ 0.2226) at birth. In addition, the change in skinfold thicknesses correlated positively with the change in the serum LPLm concentration (r ¼ 0.566, P ¼ 0.0002) and with the change in the serum IGF-I concentration (r ¼ 0.511, P ¼ 0.0009). In multiple regression analysis, serum LPLm and IGF-I concentrations at 1 month were significant and independent determinants for the changes during the first month (r ¼ 0.776, Po0.0001).
The birth weight Z-score was obtained by comparing the birth weight to the standard birth weight for a given sex and gestational week (Ogawa et al., 1998) . At birth, the birth weight Z-score had a positive association with the sum of skinfold thicknesses (r ¼ 0.583, Po0.0001), the serum LPLm concentration (r ¼ 0.633, Po0.0001), and the serum IGF-I concentration (r ¼ 0.568, Po0.0001). However, at 1 month of age, these associations disappeared (Table 4 ). The percent increase over 1 month in serum LPLm and IGF-I concentrations correlated inversely with the birth weight Z-score (r ¼ À0.639, Po0.0001; r ¼ À0.404, P ¼ 0.0053, respectively) ( Figure 1) .
We found 13 exclusively breast-fed, 8 exclusively formulafed, and 26 mix-fed infants in this study. No significant Serum lipoprotein lipase mass concentration and subcutaneous fat accumulation K Yoshikawa et al difference was observed among three feeding groups in sum of skinfold thicknesses (P ¼ 0.5576), the gain of skinfold thicknesses (P ¼ 0.6258), serum LPLm (P ¼ 0.1611), and IGF-I (P ¼ 0.2141) concentrations or the change in serum LPLm (P ¼ 0.5308) and IGF-I (P ¼ 0.2450) concentrations.
Discussion
In this study, we showed that neonate infants had serum LPLm concentrations, and then the levels increased markedly at 1 month. We also found that serum LPLm and IGF-I concentrations were the significant determinants of subcutaneous fat accumulation during the first month of life. On the other hand, at birth, serum LPLm concentration, not serum IGF-I concentrations, was the determinant of the sum of skinfold thicknesses. These suggested that serum LPLm concentrations might represent subcutaneous fat accumulation during the fetal and early neonatal periods. Furthermore, the inverse association between serum LPLm concentrations and VLDL-TG concentrations suggested that LPL-mediated TG uptake from VLDLs might be one of the major mechanisms of rapid growth in subcutaneous fat tissue.
In adult studies, serum LPLm concentrations had a positive correlation with high-density lipoprotein cholesterol concentrations and a negative correlation with VLDL-TG concentrations. In addition, it has been shown that serum LPLm concentrations are lower in conditions in which TG catabolism is disturbed, such as hypertriglyceridemia or increased remnant lipoproteins (Watanabe et al., 1999) . Thus, serum LPLm concentration may be useful as a biomarker of metabolic syndrome (Saiki et al., 2007) , despite the fact that circulating LPLm is enzymatically inactive. In this study, we found that the serum LPLm concentrations in neonates also had a significant inverse relationship with VLDL-TG concentrations, although their VLDL-TG concentrations were markedly lower than those in adults. Our results suggest that serum LPLm concentrations may be a biomarker of physiological VLDL-TG catabolism, independent of TG levels.
During the early neonatal period, subcutaneous skinfold thickness grows rapidly in parallel with the change in fat cell size (Häger et al., 1977; Knittle et al., 1979; Soriguer Escofet et al., 1996) . This study showed that this rapid growth was accompanied by a marked increase in serum LPLm concentration. Therefore, LPL-mediated TG uptake from VLDLs may be an important pathway for accumulating subcutaneous fat. However, apolipoproteins and other modulators, such as VLDL receptor and fatty acid proteins, may affect LPL activity (Voshol et al., 2009) . The contribution of these factors to subcutaneous fat accumulation in infants should be investigated in further studies.
Another important finding of this study was the association between birth weight Z-score and the postnatal change in individual serum LPLm and IGF-I concentrations. At birth, neonates with a lower birth weight Z-score had lower serum LPLm and IGF-I concentrations; but the concentrations caught up after 1 month. In healthy fullterm neonates, rapid postnatal weight gain during the first week of life was linked to a spurt of IGF-I (Skalkidou et al., 2003) , but not to adiponectin or leptin (Petridou et al., 2004 ). In addition, formula feeding has been associated with rapid weight gain in early infancy, and formula-fed infants had higher IGF-I, and an association between birth weight Z-scores and triceps skinfold thicknesses (Stettler et al., 2005) . Therefore, IGF-I may be a factor contributing to the early catch-up growth. In this study, the birth weight Z-score had a positive relationship with the sum of skinfold thicknesses at birth, but not at 1 month. However, the positive association between the birth weight Z-score and body weight remained at 1 month. This suggested that a catch up in skinfold thickness developed before the body weight catch up. Moreover, we showed that the birth weight Z-score had an inverse association with the postnatal changes in individual serum LPLm concentrations, as well as serum IGF-I concentrations. Thus, LPL may be another important player that regulates rapid postnatal growth, especially in subcutaneous fat accumulation. In a study with extremely preterm infants, born at o32 weeks gestational age, the accelerated postnatal weight gain was also accompanied by increased subcutaneous adiposity (Uthaya et al., 2005) . However, their adipose tissue distribution is altered at age term equivalent with increased intraabdominal adiposity. The contribution of LPL to intraabdominal fat accumulation should be investigated in further studies.
In conclusion, during the first month of life, serum LPLm concentrations represent the physiological catabolic state of VLDL-TG, and have a close relationship with subcutaneous fat accumulation. Moreover, LPL, as well as IGF-I, may contribute to catch-up growth in smaller neonates. Further follow-up studies are necessary in order to evaluate whether LPLm concentrations in neonates can predict future metabolic impairments.
